Suppr超能文献

微小RNA-494是侵袭性人类肝细胞癌肿瘤中多种侵袭抑制性微小RNA的主要表观遗传调节因子,它通过靶向10-11易位甲基胞嘧啶双加氧酶1发挥作用。

MicroRNA-494 is a master epigenetic regulator of multiple invasion-suppressor microRNAs by targeting ten eleven translocation 1 in invasive human hepatocellular carcinoma tumors.

作者信息

Chuang Kuang-Hsiang, Whitney-Miller Christa L, Chu Chin-Yi, Zhou Zhongren, Dokus M Katherine, Schmit Shannon, Barry Christopher T

机构信息

The Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY.

Department of Surgery Research, University of Rochester Medical Center, Rochester, NY.

出版信息

Hepatology. 2015 Aug;62(2):466-80. doi: 10.1002/hep.27816. Epub 2015 May 6.

Abstract

UNLABELLED

Vascular invasion provides a direct route for tumor metastasis. The degree to which microRNA (miRNA) expression plays a role in tumor vascular invasion is unclear. Here, we report that miR-494 is up-regulated in human hepatocellular carcinoma (HCC) tumors with vascular invasion and can promote HCC cell invasiveness by gene inactivation of multiple invasion-suppressor miRNAs. Our results show that ten eleven translocation (TET) methylcytosine dioxygenase, predominantly TET1 in HCC cells, is a direct target of miR-494. The reduced 5'-hydroxymethylcytosine levels observed in the proximal cytosine-phosphate-guanine (CpG) regions of multiple invasion-suppressor miRNA genes are strongly associated with their transcriptional repression upon miR-494 overexpression, whereas enforced DNA demethylation can abolish the repression. Furthermore, TET1 knockdown shows a similar effect as miR-494 overexpression. Conversely, miR-494 inhibition or enforced TET1 expression is able to restore invasion-suppressor miRNAs and inhibit miR-494-mediated HCC cell invasion.

CONCLUSIONS

miR-494 can trigger gene silencing of multiple invasion-suppressor miRNAs by inhibiting genomic DNA demethylation by direct targeting of TET1, thereby leading to tumor vascular invasion.

摘要

未标记

血管侵袭为肿瘤转移提供了一条直接途径。微小RNA(miRNA)表达在肿瘤血管侵袭中所起的作用程度尚不清楚。在此,我们报告miR-494在伴有血管侵袭的人类肝细胞癌(HCC)肿瘤中上调,并且可通过使多种侵袭抑制性miRNA基因失活来促进HCC细胞的侵袭性。我们的结果表明,十 - 十一易位(TET)甲基胞嘧啶双加氧酶,在HCC细胞中主要是TET1,是miR-494的直接靶点。在多种侵袭抑制性miRNA基因的近端胞嘧啶 - 磷酸 - 鸟嘌呤(CpG)区域观察到的5'-羟甲基胞嘧啶水平降低与miR-494过表达时它们的转录抑制密切相关,而强制DNA去甲基化可消除这种抑制。此外,TET1敲低显示出与miR-494过表达类似的效果。相反,miR-494抑制或强制TET1表达能够恢复侵袭抑制性miRNA并抑制miR-494介导的HCC细胞侵袭。

结论

miR-494可通过直接靶向TET1抑制基因组DNA去甲基化,从而引发多种侵袭抑制性miRNA的基因沉默,进而导致肿瘤血管侵袭。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d8a/4682466/b0547f3d6c61/hep0062-0466-f1.jpg

相似文献

2
MiR-520b suppresses proliferation of hepatoma cells through targeting ten-eleven translocation 1 (TET1) mRNA.
Biochem Biophys Res Commun. 2015 May 8;460(3):793-8. doi: 10.1016/j.bbrc.2015.03.108. Epub 2015 Mar 28.
7
MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4.
Oncotarget. 2016 Nov 8;7(45):74059-74073. doi: 10.18632/oncotarget.12190.
9
miR-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT/TCF-4 pathway.
Oncol Rep. 2014 Jan;31(1):397-404. doi: 10.3892/or.2013.2831. Epub 2013 Nov 1.
10
MicroRNA-24 increases hepatocellular carcinoma cell metastasis and invasion by targeting p53: miR-24 targeted p53.
Biomed Pharmacother. 2016 Dec;84:1113-1118. doi: 10.1016/j.biopha.2016.10.051. Epub 2016 Oct 22.

引用本文的文献

1
Ten-Eleven Translocation Family Proteins: Structure, Biological Functions, Diseases, and Targeted Therapy.
MedComm (2020). 2025 Jul 1;6(7):e70245. doi: 10.1002/mco2.70245. eCollection 2025 Jul.
2
TET1: The epigenetic architect of clinical disease progression.
Genes Dis. 2025 Jan 4;12(5):101513. doi: 10.1016/j.gendis.2025.101513. eCollection 2025 Sep.
3
MicroRNA-494 augments fibrotic transformation of human retinal pigment epithelial cells and targets p27 with cell-type specificity.
Front Ophthalmol (Lausanne). 2023 Apr 14;3:1168650. doi: 10.3389/fopht.2023.1168650. eCollection 2023.
5
ncRNAs-mediated overexpression of predicts unfavorable prognosis and correlates with immunotherapy efficacy in breast cancer.
Heliyon. 2024 Jan 18;10(3):e24855. doi: 10.1016/j.heliyon.2024.e24855. eCollection 2024 Feb 15.
6
TET (Ten-eleven translocation) family proteins: structure, biological functions and applications.
Signal Transduct Target Ther. 2023 Aug 11;8(1):297. doi: 10.1038/s41392-023-01537-x.
7
Circular RNAs in hepatocellular carcinoma: biogenesis, function, and pathology.
Front Genet. 2023 Jul 7;14:1106665. doi: 10.3389/fgene.2023.1106665. eCollection 2023.
10
Mechanisms that regulate the activities of TET proteins.
Cell Mol Life Sci. 2022 Jun 15;79(7):363. doi: 10.1007/s00018-022-04396-x.

本文引用的文献

1
Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and β-catenin signaling in pancreatic ductal adenocarcinoma cells.
Gastroenterology. 2014 Aug;147(2):485-97.e18. doi: 10.1053/j.gastro.2014.04.048. Epub 2014 May 20.
4
MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation.
Proc Natl Acad Sci U S A. 2012 Oct 9;109(41):16570-5. doi: 10.1073/pnas.1207917109. Epub 2012 Sep 24.
5
TET1 suppresses cancer invasion by activating the tissue inhibitors of metalloproteinases.
Cell Rep. 2012 Sep 27;2(3):568-79. doi: 10.1016/j.celrep.2012.08.030. Epub 2012 Sep 20.
6
The role of mutations in epigenetic regulators in myeloid malignancies.
Nat Rev Cancer. 2012 Sep;12(9):599-612. doi: 10.1038/nrc3343. Epub 2012 Aug 17.
7
Non-coding RNAs as therapeutic targets in hepatocellular cancer.
Curr Cancer Drug Targets. 2012 Nov 1;12(9):1073-80.
8
Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation.
Oncogene. 2013 Jan 31;32(5):663-9. doi: 10.1038/onc.2012.67. Epub 2012 Mar 5.
9
Hepatocellular carcinoma.
Lancet. 2012 Mar 31;379(9822):1245-55. doi: 10.1016/S0140-6736(11)61347-0. Epub 2012 Feb 20.
10
Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation.
Cancer Sci. 2012 Apr;103(4):670-6. doi: 10.1111/j.1349-7006.2012.02213.x. Epub 2012 Feb 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验